PAI
ARKG icon

Pittenger & Anderson Inc’s ARK Genomic Revolution ETF ARKG Stock Holding History

Pittenger & Anderson Inc’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-325
Closed -$15K – 433
2022
Q1 		$15K Hold
325
– – ﹤0.01% 332
2021
Q4 		$20K Sell
325
-2,455
-88% -$170K ﹤0.01% 308
2021
Q3 		$208K Buy
2,780
+80
+3% +$6.71K 0.01% 200
2021
Q2 		$250K Buy
2,700
+345
+15% +$29.3K 0.01% 188
2021
Q1 		$209K Buy
+2,355
New +$234K 0.01% 196

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Pittenger & Anderson Inc's ARKG Position: Q2 2022 in Review

Pittenger & Anderson Inc sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 325 shares — an estimated $15K sold.

Pittenger & Anderson Inc first reported a position in ARKG in Q1 2021 and held it in 5 quarters. The position peaked at $250K in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • Pittenger & Anderson Inc reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 325 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $15K.
  • Pittenger & Anderson Inc first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 5 quarters.
  • Pittenger & Anderson Inc's ARK Genomic Revolution ETF position peaked at $250K in Q2 2021.
  • 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2022, filed 14 Jul 2022.